EZH2蛋白在人胎儿器官发育过程中的表达模式

doi:10.3969/j.issn.1004-616x.2014.04.002

摘要/Abstract

摘要：

目的：检测果蝇zeste基因增强子人类同源物2(EZH2)蛋白在人胎儿发育过程中的表达模式，为了解EZH2在胎儿发育过程中可能的作用，提供新的、多器官的信息。方法：收集不同胎龄流产或死产胎儿33例及1例新生儿标本。选取食管、胃、小肠、结肠、肝、胰、腮腺、甲状腺、肾上腺、肺、气管、心脏、大血管(主动脉或肺动脉)、肾、膀胱、子宫、卵巢、睾丸、脾、胸腺、大脑等器官组织，经HE染色辨别形态学结构并构建组织芯片后，进行EZH2免疫组化染色检测。结果：在所有检测的上述胎儿器官中EZH2蛋白均有表达，但在不同的组织器官和不同的胎龄其表达水平不同。EZH2蛋白阳性染色主要定位于细胞核，在部分细胞同时也有细胞质阳性染色。结论：EZH2在人类胎儿期的各器官组织均有表达，表达模式有胎儿发育时间的差异性和高度的组织特异性。

关键词: zeste基因增强子人类同源物2, 胚胎, 发育, 表达模式

Abstract:

OBJECTIVE: To determine the expression pattern of EZH2 protein in the process of human fetal development and provide new and multi-organ information for understanding the possible roles of EZH2 during the whole fetal development. METHODS：33 human fetuses at 25 different gestational weeks and 1 neonatal sample were obtained through abortion or stillbirth. The organ or tissue including esophagus，stomach，small intestine，colon，liver， pancreas，parotid gland，thyroid，adrenal gland，lung，trachea，heart，large artery，kidney，bladder，uterus， ovary，testis，spleen，thymus，cerebrum were fixed，embedded，sectioned，then stained with hematoxylin and eosin to identify their morphological structures. Tissue microarrays were constructed and followed by immunohistochemical staining of EZH2. RESULTS：EZH2 was expressed in fetal organs investigated and exhibited different expression levels in different tissues and at various gestational ages. The positive staining of EZH2 protein was mainly located in the nucleus，as well as in the cytoplasm in some cells. CONCLUSION：EZH2 protein was generally expressed in human fetal organs and tissues and its expression exhibited tissue specificity and dependence on the stages of fetal development.

Key words: enhancer zeste homologue 2, fetus, development, expression pattern

刘淑岩，祝宁侠，陈海滨. EZH2蛋白在人胎儿器官发育过程中的表达模式[J]. 癌变·畸变·突变, doi: 10.3969/j.issn.1004-616x.2014.04.002.

LIU Shu-yan，ZHU Ning-xia，CHEN Hai-bin. Expression pattern of EZH2 in oganogenesis of human fetuses[J]. Carcinogenesis, Teratogenesis & Mutagenesis, doi: 10.3969/j.issn.1004-616x.2014.04.002.

参考文献

[1] Schuettengruber B，Chourrout D，Vervoort M，et al. Genome regulation by polycomb and trithorax proteins[J]. Cell，2007， 128(4)：735-745.

[2] Lewis EB. A gene complex controlling segmentation in Drosophila[J]. Nature，1978，276(5688)：565-570.

[3] Simon JA，Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics[J]. Mutat Res，2008， 647(1/2)：21-29.

[4] Cao Q，Wang X，Zhao M，et al. The central role of EED in the orchestration of polycomb group complexes[J]. Nat Commun， 2014，5：3127.

[5] Chen YH，Hung MC，Li LY. EZH2：a pivotal regulator in controlling cell differentiation[J]. Am J Transl Res，2012， 4(4)：364-375.

[6] Montgomery ND，Yee D，Chen A，et al. The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation[J]. Curr Biol，2005，15(10)：942-947.

[7] Huang XJ，Wang X，Ma X，et al. EZH2 is essential for development of mouse preimplantation embryos[J]. Reprod Fertil Dev，2013. doi：10.1071/RD13169.

[8] Laible G，Wolf A，Dorn R，et al. Mammalian homologues of the Polycomb-group gene Enhancer of zeste mediate gene silencing in Drosophila heterochromatin and at S. cerevisiae telomeres[J]. EMBO J，1997，16(11)：3219-3232.

[9] Ogawa M，Hiraoka Y，Taniguchi K，et al. Cloning and expression of a human/mouse Polycomb group gene，ENX-2/Enx-2[J]. Biochim Biophys Acta，1998，1395(2)：151-158.

[10] Varambally S，Dhanasekaran SM，Zhou M，et al. The polycomb group protein EZH2 is involved in progression of prostate cancer[J]. Nature，2002，419(6907)：624-629.

[11] Yang YA，Yu J. EZH2，an epigenetic driver of prostate cancer[J]. Protein Cell，2013，4(5)：331-341.

[12] Deb G，Thakur VS，Gupta S，et al. Multifaceted role of EZH2 in breast and prostate tumorigenesis：epigenetics and beyond[J]. Epigenetics，2013，8(5)：464-476.

[13] Caganova M，Carrisi C，Varano G，et al. Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis[J]. J Clin Invest，2013，123(12)：5009-5022.

[14] Lin YW，Ren LL，Xiong H，et al. Role of STAT3 and vitamin D receptor in EZH2-mediated invasion of human colorectal cancer[J]. J Pathol，2013，230(3)：277-290.

[15] Behrens C，Solis LM，Lin H，et al. EZH2 protein expression associates with the early pathogenesis，tumor progression，and prognosis of non-small cell lung carcinoma[J]. Clin Cancer Res，2013，19(23)：6556-6565.

[16] He LJ，Cai MY，Xu GL，et al. Prognostic significance of overexpression of EZH2 and H3k27me3 proteins in gastric cancer[J]. Asian Pac J Cancer Prev，2012，13(7)：3173-3178.

[17] Ougolkov AV，Bilim VN，Billadeau DD. Regulation of pancreatic tumor cell proliferation and chemoresistance by the histone methyltransferase enhancer of zeste homologue 2[J]. Clin Cancer Res，2008，14(21)：6790-6796.

[18] Zhao L，Yu Y，Wu J，et al. Role of EZH2 in oral squamous cell carcinoma carcinogenesis[J]. Gene，2014，537(2)：197-202.

[19] Ciarapica R，Miele L，Giordano A，et al. Enhancer of zeste homolog 2 (EZH2) in pediatric soft tissue sarcomas：first implications[J]. BMC Medicine，2011，9：63.

[20] Liu Y，Liu T，Bao X，et al. Increased EZH2 expression is associated with proliferation and progression of cervical cancer and indicates a poor prognosis[J]. Int J Gynecol Pathol，2014， 33(3)：218-224.

[21] Eskander RN，Ji T，Huynh B，et al. Inhibition of enhancer of zeste homolog 2 (EZH2) expression is associated with decreased tumor cell proliferation，migration，and invasion in endometrial cancer cell lines[J]. Int J Gynecol Cancer，2013，23(6)：997-1005.

[22] Xu B，Abourbih S，Sircar K，et al. Enhancer of zeste homolog 2 expression is associated with metastasis and adverse clinical outcome in clear cell renal cell carcinoma：a comparative study and review of the literature[J]. Arch Pathol Lab Med，2013， 137(10)：1326-1336.

[23] Hayashi A，Morikawa T，Kawai T，et al. Clinicopathological and prognostic significance of EZH2 expression in upper urinary tract carcinoma[J]. Virchows Arch，2014，464(4)：463-471.

[24] Chang CJ，Hung MC. The role of EZH2 in tumour progression[J]. Br J Cancer，2012，106(2)：243-247.

[25] Tsang DP，Cheng AS. Epigenetic regulation of signaling pathways in cancer：role of the histone methyltransferase EZH2[J]. J Gastroenterol Hepatol，2011，26(1)：19-27.

[26] Schwarz D，Varum S，Zemke M，et al. Ezh2 is required for neural crest-derived cartilage and bone formation[J]. Development，2014，141(4)：867-877.

[27] Margueron R，Li G，Sarma K，et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms[J]. Mol Cell，2008，32(4)：503-518.

[28] Zhu Ningxia，Liu Shuyan，Su Zhongjing，et al. The expression pattern of polycomb group protein Ezh2 during mouse embryogenesis[J]. Anat Rec，2011，294(7)：1150-1157.

[29] Su IH，Dobenecker MW，Dickinson E，et al. Polycomb group protein Ezh2 controls actin polymerization and cell signaling[J]. Cell，2005，121(3)：425-436.

[30] Bryant RJ，Winder SJ，Cross SS，et al. The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells[J]. Prostate，2008，68(3)：255-263.